210 related articles for article (PubMed ID: 25297758)
1. [Advances in management of follicular lymphoma].
Zinzani PL
Rinsho Ketsueki; 2014 Oct; 55(10):1937-40. PubMed ID: 25297758
[No Abstract] [Full Text] [Related]
2. [Management of follicular lymphoma].
Izutsu K
Rinsho Ketsueki; 2014 Oct; 55(10):1929-36. PubMed ID: 25297757
[No Abstract] [Full Text] [Related]
3. It is follicular... . so, why CHOP?
Nabhan C
J Clin Oncol; 2007 Mar; 25(7):915-6; author reply 916-7. PubMed ID: 17327620
[No Abstract] [Full Text] [Related]
4. Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.
Derenzini E; Casadei B; Broccoli A; Gandolfi L; Pellegrini C; Zinzani PL
Br J Haematol; 2014 Aug; 166(4):625-8. PubMed ID: 24750128
[No Abstract] [Full Text] [Related]
5. Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study.
Illidge TM; McKenzie HS; Mayes S; Bates A; Davies AJ; Pettengell R; Stanton L; Cozens K; Hampson G; Dive C; Zivanovic M; Tipping J; Gallop-Evans E; Radford JA; Johnson PW
Br J Haematol; 2016 Apr; 173(2):274-82. PubMed ID: 26849853
[TBL] [Abstract][Full Text] [Related]
6. Follicular lymphoma: 2012 update on diagnosis and management.
Freedman A
Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
[TBL] [Abstract][Full Text] [Related]
7. [Current treatment of follicular lymphoma].
Bonnet C; Beguin Y; Deprijck B; de Leval L; Fillet G
Rev Med Suisse; 2009 Aug; 5(214):1663-7. PubMed ID: 19772198
[TBL] [Abstract][Full Text] [Related]
8. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma.
Clin Adv Hematol Oncol; 2006 Jul; 4(7):536-8. PubMed ID: 17147240
[No Abstract] [Full Text] [Related]
9. Current immunochemotherapy strategies in follicular lymphoma.
Giné E; Gutiérrez-García G; López-Guillermo A
Adv Ther; 2010 Oct; 27(10):704-13. PubMed ID: 20820973
[TBL] [Abstract][Full Text] [Related]
10. Overview of Southwest Oncology Group Clinical Trials in non-Hodgkin Lymphoma. S0016. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + iodine131-labeled monoclonal anti-B1 antibody (tositumomab) for treatment of newly diagnosed follicular NHL.
Fisher RI
Clin Adv Hematol Oncol; 2005 Jul; 3(7):544-6. PubMed ID: 16167036
[No Abstract] [Full Text] [Related]
11. Chemotherapy: maintenance rituximab for relapsed follicular lymphoma.
Wrench D; Montoto S
Nat Rev Clin Oncol; 2010 Dec; 7(12):677-8. PubMed ID: 21116237
[No Abstract] [Full Text] [Related]
12. The rapidly expanding role of rituximab in the treatment of aggressive B-cell lymphoma.
Cooper D
Cancer J; 2002; 8(5):364-6. PubMed ID: 12416891
[No Abstract] [Full Text] [Related]
13. [Immunotherapy with monoclonal antibody of malignant lymphoma].
Ogura M
Nihon Rinsho; 2007 Jan; 65 Suppl 1():545-60. PubMed ID: 17474462
[No Abstract] [Full Text] [Related]
14. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
Ogura M
Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928
[No Abstract] [Full Text] [Related]
15. [Recent progress in the therapeutic strategy for follicular lymphoma and mantle cell lymphoma].
Ogura M
Rinsho Ketsueki; 2006 Jun; 47(6):495-512. PubMed ID: 16862978
[No Abstract] [Full Text] [Related]
16. Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma.
Arcaini L; Orlandi E; Scotti M; Brusamolino E; Passamonti F; Burcheri S; Colombo N; Vanelli L; Sbalzarini G; Lazzarino M
Clin Lymphoma; 2004 Mar; 4(4):250-2. PubMed ID: 15072617
[TBL] [Abstract][Full Text] [Related]
17. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study.
Martin P; Byrtek M; Dawson K; Ziemiecki R; Friedberg JW; Cerhan JR; Flowers CR; Link BK
Cancer; 2013 Dec; 119(23):4129-36. PubMed ID: 24006156
[TBL] [Abstract][Full Text] [Related]
18. [Rituximab, a chimeric mouse-human anti-CD20 monoclonal antibody].
Tobinai K
Nihon Rinsho; 2002 Mar; 60(3):468-72. PubMed ID: 11904960
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.
Press OW; Unger JM; Braziel RM; Maloney DG; Miller TP; Leblanc M; Fisher RI;
J Clin Oncol; 2006 Sep; 24(25):4143-9. PubMed ID: 16896003
[TBL] [Abstract][Full Text] [Related]
20. The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma.
Andresen S; Brandt J; Dietrich S; Memmer ML; Ho AD; Witzens-Harig M
Leuk Lymphoma; 2012 Mar; 53(3):386-93. PubMed ID: 21864036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
